Two mathematicians have proved that a straightforward question—how hard is it to untie a knot?—has a complicated answer.

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

The new big thing in magnetics is altermagnetism, a form of magnetism that promises to power the next generation of ...

Currently, scientists struggle to forecast volcano eruption events, as no universally reliable, real-time eruption ...

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...

Scotiabank initiated coverage of Vertex Pharmaceuticals (VRTX) with an Outperform rating and $495 price target Published first on TheFly – the ...

The Find X is a near bezel-less phone from smartphone maker Oppo. In order to achieve the big display design, Oppo positioned the selfie camera, face recognition hardware and the rear cameras in a ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.